Hypericin as a Marker for Determination of Tissue Viability After Intratumoral Ethanol Injection in a Murine Liver Tumor Model

Academic Radiology

Volumn 15, Issue 1, 2008, Pages 107-113

  Van de Putte, Marie ^a   Wang, Huaijun ^a   Chen, Feng ^a   de Witte, Peter A M ^a   Ni, Yicheng ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

ethanol injection; hypericin; liver neoplasm; NACA; Necrosis

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; HYPERICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRAVASATION; FEMALE; FIBROSARCOMA; FLUORESCENCE; FLUOROSCOPY; IMAGE ANALYSIS; LIVER TUMOR; MICROSCOPY; MORPHOLOGY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME; TUMOR MODEL;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; ETHANOL; FEMALE; FIBROSARCOMA; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MICE; MICROSCOPY, FLUORESCENCE; NECROSIS; NEOPLASM TRANSPLANTATION; PERYLENE;

EID: 36749065586     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2007.08.008     Document Type: Article

References (22)

1. Steele G., and Ravikumar T. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210 (1989) 127-138
2. Livraghi T., Festi D., Monti F., et al. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 161 (1986) 309-312
3. Shiina S., Yasuda H., Muto H., et al. Percutaneous ethanol injection in the treatment of liver neoplasms. Am J Roentgenol 149 (1987) 949-952
4. Bartolozzi C., Lencioni R., Caramella D., et al. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology 191 (1994) 123-128
5. Lin X., and Lin L. Local injection therapy for hepatocellular carcinoma. Hepatobil Pancreat Dis Int 5 (2006) 16-21
6. Vogl T., Eichler K., Zangos S., et al. Hepatocellular carcinoma: role of imaging diagnostics in detection, intervention and follow-up. Rofo 174 (2002) 1358-1368
7. Bartolozzi C., and Lencioni R. Ethanol injection for the treatment of hepatic tumours. Eur Radiol 6 (1996) 682-696
8. Nagel H., and Bernardino M. Contrast-enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy. Radiology 189 (1993) 265-270
9. Cioni D., Lencioni R., and Bartolozzi C. Percutaneous ablation of liver malignancies: imaging evaluation of treatment response. Eur J Ultrasound 13 (2001) 73-93
10. Ni Y., Bormans G., Chen F., et al. Necrosis avid contrast agents: functional similarity versus structural diversity. Invest Radiol 40 (2005) 526-535
11. Ni Y., Chen F., Mulier S., et al. Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis avid contrast agent. Eur Radiol 16 (2006) 1031-1040
12. Giese A. Hypericism. Photochem Photobiol Rev 5 (1980) 229-255
13. Kartnig T., Gobel I., and Heydel B. Production of hypericin, pseudohypericin and flavonoids in cell cultures of various Hypericum species and their chemotypes. Planta Med 62 (1996) 51-53
14. D'Hallewin M., De Witte P., Waelkens E., et al. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J Urol 164 (2000) 349-351
15. Kamuhabwa A., Agostinis P., Ahmed B., et al. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder. Photochem Photobiol Sci 3 (2004) 772-780
16. Ni Y., Huyghe D., Verbeke K., et al. First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent. Eur J Nucl Med Mol Imaging 33 (2006) 595-601
17. Twentyman P., Brown J., Gray J., et al. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst 64 (1980) 595-604
18. Chen F., Sun X., De Keyzer F., et al. Liver tumor model with implanted rhabdomyosarcoma in rats: MR imaging, microangiography, and histopathologic analysis. Radiology 239 (2006) 554-562
19. Falk H., Meyer J., and Oberreiter M. A convenient semisynthetic route to hypericin. Monatsh Chem 124 (1993) 339-341
20. Ni Y., and Marchal G. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments. Topics in Magn Reson Imaging 9 (1998) 183-195
21. Chen B., Xu Y., Roskams T., Delaey E., et al. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 93 (2001) 275-282
22. Guan Y., Sun L., Zhou X., et al. Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up. World J Gastroenterol 10 (2004) 3543-3548